Summit Therapeutics signs agreement to sell phase III asset ridinilazole to Biossil: Miami Wednesday, July 15, 2026, 18:00 Hrs [IST] Summit Therapeutics Inc., a biopharmaceutical ...

The expanded BRICS bloc has emerged as a cornerstone of the "global majority," accounting for nearly 40 percent of global GDP ...

Takeda and the Indonesian Government collaborate to strengthen healthcare resilience and expand access to lifesaving plasma-derived medicinal products: Osaka, Japan Tuesday, July ...

MoSPI introduces the Index of Services Production with April 2026 trial data to provide a high-frequency measure of formal ...

The boardroom has become a central locus of responsibility in the federal government’s campaign against money laundering. Once considered a ...

Digitized R&D workflows help cell therapy developers reduce manual data handling and accelerate biologics development.

They can be a secure way to avoid outliving assets—but watch out for fees Katharine Paljug is a financial writer and editor with over a decade of industry experience. Her writing has covered nearly ...

Mark Cussen, CMFC, has 13+ years of experience as a writer and provides financial education to military service members and the public. Mark is an expert in investing, economics, and market news.